IXJ:NYE-iShares Global Healthcare ETF (USD)

ETF | Health |

Last Closing

USD 97.32

Change

-0.26 (-0.27)%

Market Cap

N/A

Volume

0.08M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-02 )

Largest Industry Peers for Health

Symbol Name Price(Change) Market Cap
XLV Health Care Select Sector SPDR..

-0.31 (-0.20%)

USD 41.71B
FHLC Fidelity® MSCI Health Care In..

-0.08 (-0.11%)

USD 2.97B
FXH First Trust Health Care AlphaD..

-0.78 (-0.71%)

USD 1.29B
XHE SPDR® S&P Health Care Equipme..

-0.33 (-0.37%)

USD 0.22B
IDNA iShares Genomics Immunology an..

+0.03 (+0.12%)

USD 0.14B
SBIO ALPS Medical Breakthroughs ETF

+0.02 (+0.06%)

USD 0.11B
XHS SPDR® S&P Health Care Service..

-0.11 (-0.12%)

USD 0.08B
HTEC Robo Global® Healthcare Techn..

-0.02 (-0.06%)

USD 0.06B
BBP Virtus LifeSci Biotech Product..

+0.70 (+1.13%)

USD 0.02B
BBC Virtus LifeSci Biotech Clinica..

+0.05 (+0.18%)

USD 0.01B

ETFs Containing IXJ

IXJ:AU iShares Global Healthcare.. 99.88 % 0.00 %

+0.18 (+0.13%)

USD 1.46B
XHC:CA iShares Global Healthcare.. 0.00 % 0.65 %

-0.20 (0.13%)

CAD 0.65B

Market Performance

  Market Performance vs. Industry/Classification (Health) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 12.22% 76% C+ 62% D
Dividend Return 0.78% 63% D 12% F
Total Return 13.00% 76% C+ 57% F
Trailing 12 Months  
Capital Gain 19.24% 33% F 51% F
Dividend Return 1.51% 83% B 20% F
Total Return 20.74% 38% F 46% F
Trailing 5 Years  
Capital Gain 59.99% 71% C- 73% C
Dividend Return 6.31% 72% C 19% F
Total Return 66.29% 71% C- 71% C-
Average Annual (5 Year Horizon)  
Capital Gain 7.46% N/A N/A 62% D
Dividend Return 8.42% N/A N/A 57% F
Total Return 0.96% N/A N/A 22% F
Risk Return Profile  
Volatility (Standard Deviation) 10.70% N/A N/A 76% C+
Risk Adjusted Return 78.71% N/A N/A 89% A-
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike